Spirometra IgG ELISA Kit

The Spirometra IgG ELISA Kit is a qualitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgG antibodies specific to Spirometra erinaceieuropaei in human serum or plasma samples. Sparganosis is a parasitic infection caused by the larval stage (spargana) of Spirometra species, which primarily affects humans in Southeast Asia and tropical regions but has a global distribution.

Humans acquire sparganosis by drinking water contaminated with infected copepods or consuming undercooked meat of intermediate hosts such as frogs or snakes. Spargana can migrate and parasitize subcutaneous tissues, pleural cavities, the urinary tract, and even the central nervous system for up to 20 years. Neurological symptoms, including headache, seizures, and limb weakness, may occur if spargana settle in the brain or spinal cord.

This assay uses recombinant Spirometra cysteine protease antigens coated on microplates. IgG antibodies in the patient sample bind to the antigens, triggering a colorimetric reaction for clear visual or instrumental detection. This kit provides reliable and rapid results for clinical diagnosis and epidemiological investigations of sparganosis.

Spirometra IgG ELISA Kit

√  High Sensitivity: Achieves 100% sensitivity for detecting specific IgG antibodies.

√  High Specificity: 98% specificity minimizes false-positive results.

√  Rapid Workflow: Simplified protocol for quick and efficient testing.

√  Clear Results: Strong colorimetric reaction allows for easy visual or ELISA reader interpretation.

√  Stable Reagents: Long-term stability at 2-8°C ensures reliable performance.

√  Sample Compatibility: Suitable for both serum and plasma specimens.

√  Quality Assurance: Includes positive and negative controls for validation.

√  Standardized Process: Compliant with international diagnostic standards for consistent results.

Spirometra IgG ELISA Kit

√  Clinical Laboratories: Diagnosis and screening of sparganosis infections.

√  Public Health Centers: Conducting epidemiological surveys and monitoring high-risk populations.

√  Research Institutions: Supporting studies on sparganosis immunology and pathology.

√  Food Safety and Aquatic Agencies: Assessing the risk of foodborne parasite infections from freshwater animals.

√  Remote Healthcare Facilities: Providing accessible and rapid diagnostic tools in underserved areas.

√  International Quarantine Services: Screening travelers and workers from endemic regions.

√  Traditional Medicine and Nutrition Fields: Evaluating health risks associated with consuming frogs, snakes, or other intermediate hosts.

√  Public Health Programs: Implementing prevention and control measures in endemic regions.